83.37
price down icon2.45%   -2.09
after-market Handel nachbörslich: 83.40 0.03 +0.04%
loading

Dexcom Inc Aktie (DXCM) Neueste Nachrichten

pulisher
Jul 11, 2025

Ravens’ Mark Andrews leads first Dexcom U Signing Day Camp, inspiring young athletes with diabetes - WMAR 2 News Baltimore

Jul 11, 2025
pulisher
Jul 09, 2025

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

DexCom Is Doubling Down on Its ‘Mistake.’ Why It’s Time to Buy the Stock. - Barron's

Jul 09, 2025
pulisher
Jul 08, 2025

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day - Investegate

Jul 08, 2025
pulisher
Jul 07, 2025

What You Need To Know Ahead Of DexCom’s Earnings Release - Barchart.com

Jul 07, 2025
pulisher
Jul 02, 2025

3 Reasons Growth Investors Will Love DexCom (DXCM) - Yahoo Finance

Jul 02, 2025
pulisher
Jul 01, 2025

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time. - Business Wire

Jul 01, 2025
pulisher
Jun 30, 2025

DexCom (DXCM) Leads Healthcare Sector Gains - GuruFocus

Jun 30, 2025
pulisher
Jun 29, 2025

Oppenheimer Reaffirms DexCom Buy Rating Amid HHS Wearables Push - Yahoo Finance

Jun 29, 2025
pulisher
Jun 25, 2025

Why DexCom (DXCM) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jun 25, 2025
pulisher
Jun 18, 2025

Dexcom EVP Brown sells $41k in shares - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Diabetics at Risk: FDA Issues Highest-Level Recall on 2M Dexcom Devices Over 'Deadly Fault' - inkl

Jun 18, 2025
pulisher
Jun 18, 2025

Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight - GlobeNewswire Inc.

Jun 18, 2025
pulisher
Jun 18, 2025

Dexcom Ireland announce golfer Liam Nolan as a brand ambassador - Galway Advertiser

Jun 18, 2025
pulisher
Jun 18, 2025

Dexcom recalls more than 2 million CGM receivers for lack of audible alarm - MedTech Dive

Jun 18, 2025
pulisher
Jun 18, 2025

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Dexcom

Jun 18, 2025
pulisher
Jun 18, 2025

Breakthrough Study Reveals Doctors Choose CGM Over Medications as Future of Type 2 Diabetes Treatment - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks - FinancialContent

Jun 17, 2025
pulisher
Jun 17, 2025

Dexcom Faces TM Suit Over 'Stelo' Glucose Monitor Product - Law360

Jun 17, 2025
pulisher
Jun 17, 2025

Goldman Sachs Initiates Coverage of DexCom (DXCM) With Buy Rating - MSN

Jun 17, 2025
pulisher
Jun 17, 2025

DexCom’s SWOT analysis: CGM leader’s stock poised for growth amid challenges - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

DexCom's SWOT analysis: CGM leader's stock poised for growth amid challenges - Investing.com

Jun 17, 2025
pulisher
Jun 16, 2025

Expert Outlook: DexCom Through The Eyes Of 8 Analysts - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom Stock: Is DXCM Underperforming the Health Care Sector? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom (DXCM) Receives 'Buy' Rating from Truist Securities with $102 Price Target | DXCM Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom (DXCM) Gains Analysts' Favor Despite Past Challenges - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom Stock: Is DXCM Underperforming The Health Care Sector? - Barchart.com

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom (DXCM) Receives Buy Rating Amid Promising Market Prospects | DXCM Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Truist Initiates DexCom at Buy With $102 Price Target - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom Insiders Sell US$11m Of Stock, Possibly Signalling Caution - simplywall.st

Jun 16, 2025
pulisher
Jun 10, 2025

Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7 - MassDevice

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet Corporation's Omnipod 5 App for Iphone with Dexcom G7 Integration Now Available to All U.S. Users - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet Releases Omnipod 5 App for iPhone with Dexcom G7 CGM in U.S. - Medical Product Outsourcing

Jun 10, 2025
pulisher
Jun 10, 2025

Diabetes partnerships abound ahead of ADA - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet (PODD) Omnipod 5 App Now Compatible with Dexcom G7 on iPhone | PODD Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users | PODD Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users - Business Wire

Jun 10, 2025
pulisher
Jun 09, 2025

DexCom, Inc. (DXCM) Stock Analysis: Analyst Consensus Points to 13.59% Potential Upside - DirectorsTalk Interviews

Jun 09, 2025
pulisher
Jun 08, 2025

DexCom (NASDAQ:DXCM) Stock Rating Upgraded by Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

DexCom, Inc. (NASDAQ:DXCM) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders - GlobeNewswire

Jun 05, 2025
pulisher
Jun 04, 2025

BGM and CGM Market is Set to Experience a Revolutionary Growth | Abbott Laboratories , Dexcom, Medtronic PLC - openPR.com

Jun 04, 2025
pulisher
Jun 02, 2025

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Should You Be Excited About DexCom, Inc.'s (NASDAQ:DXCM) 24% Return On Equity? - simplywall.st

Jun 02, 2025
pulisher
Jun 01, 2025

Goldman Sachs Initiates Coverage of DexCom (XTRA:DC4) with Buy Recommendation - Nasdaq

Jun 01, 2025
pulisher
May 31, 2025

Goldman Sachs Initiates Coverage of DexCom (BIT:1DXCM) with Buy Recommendation - Nasdaq

May 31, 2025
pulisher
May 31, 2025

DexCom (NASDAQ:DXCM) Now Covered by Analysts at The Goldman Sachs Group - Defense World

May 31, 2025
pulisher
May 30, 2025

Goldman Sachs Initiates Coverage of DexCom (DXCM) with Buy Recommendation - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Forecasting The Future: 7 Analyst Projections For DexCom - Benzinga

May 30, 2025
pulisher
May 30, 2025

DexCom, Inc. (NASDAQ:DXCM) Q2 2024 Earnings Call Transcript - MSN

May 30, 2025
pulisher
May 30, 2025

Jefferies Adjusts Price Target on DexCom to $110 From $105, Maintains Buy Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Goldman Sachs Initiates DexCom at Buy With $104 Price Target - marketscreener.com

May 30, 2025
pulisher
May 29, 2025

DexCom (DXCM) Receives Positive Coverage with Growth Potential | - GuruFocus

May 29, 2025
pulisher
May 29, 2025

DexCom (DXCM) Receives Positive Coverage with Growth Potential | DXCM Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Dexcom’s EVP Sadie Stern sells $526,318 in shares - Investing.com

May 28, 2025
pulisher
May 27, 2025

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program - The Globe and Mail

May 27, 2025
pulisher
May 26, 2025

DexCom, Inc. (DXCM) Stock Analysis: 15.97% Potential Upside Amid Robust Analyst Support - DirectorsTalk Interviews

May 26, 2025
$75.13
price down icon 1.79%
medical_devices STE
$228.03
price down icon 1.17%
medical_devices EW
$78.05
price down icon 0.95%
medical_devices PHG
$24.03
price down icon 2.55%
$289.32
price down icon 2.72%
Kapitalisierung:     |  Volumen (24h):